Ribometrix
Greenville, US · Founded 2014 · North Carolina corporation · 8 known investors
Founders & leadership
Ribometrix was founded in 2014 by Kevin Weeks.
KW
Kevin WeeksFounder
KW
Katherine WarnerNamed on SEC filing
JR
Joshua ResnickNamed on SEC filing
MS
Michael SolomonNamed on SEC filing
JG
John GustofsonNamed on SEC filing
Board
Investors · 8
Illumina VenturesFoster City
M VenturesLos Angeles · $10.8M
MC Healthcare VenturesCambridge
Pappas CapitalDurham
SV Health InvestorsBoston · $1M – $20M
Dementia Discovery FundreportedLondon
Hatteras Venture Partnersreported · 2 sourcesResearch Triangle · $500K – $4M
Pappas CapitalreportedResearch Triangle Park · $100K – $6M
Reported raises · per SEC filings
Form D private placements$18.5M disclosed across 2 rounds · 2017–2018
▶$15MraisedNov 2018 · 16 investors · PharmaceuticalsRule 506(b)
▶$15MraisedNov 2018 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kevin WeeksExecutive Officer, Director
- Michael RossDirector
- Michael DialDirector
- John GustofsonDirector
- William MarshallDirector
- Katherine WarnerExecutive Officer
- Michael SolomonExecutive Officer, Director
- Hakan GokerDirector
- Offering amount
- $30M
- Amount sold
- $15M
- First sale
- Nov 2018
- Incorporated
- Corporation, North Carolina, 2014
- Federal exemptions
- 06b
▶$3.5MraisedOct 2017 · 10 investors · PharmaceuticalsRule 506(b)
▶$3.5MraisedOct 2017 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Katherine WarnerExecutive Officer
- Mike DialDirector
- Joshua ResnickDirector
- Michael SolomonDirector
- Kevin WeeksExecutive Officer, Director
- John GustofsonDirector
- Offering amount
- $7.5M
- Amount sold
- $3.5M
- Minimum investment
- $10K
- First sale
- Oct 2017
- Incorporated
- Corporation, North Carolina, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapBioworld11 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Aro Biotherapeutics8 shared keywordsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Companies competing with Ribometrix for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- Who founded Ribometrix?
- Ribometrix was founded by Kevin Weeks in 2014.
- Who are Ribometrix's investors?
- Ribometrix's investors include Illumina Ventures, M Ventures, MC Healthcare Ventures, Pappas Capital, SV Health Investors, Dementia Discovery Fund, Hatteras Venture Partners, Pappas Capital.
- How much funding has Ribometrix raised?
- Ribometrix has disclosed $18.5M raised across 2 rounds.
- Where is Ribometrix headquartered?
- Ribometrix is headquartered in Greenville, US.